As at the 31st of August 2013 the NAV of the Class A shares of the Pangolin Asia Fund was US$361.54 net of all fees and expenses, down 5.53% from US$382.69 in July. Please see the table at the end of this letter for further detail.
As at the 31st of July 2013 the NAV of the Class A shares of the Pangolin Asia Fund was US$382.69 net of all fees and expenses, up 1.78% from US$375.98 in June. Please see the table at the end of this letter for further detail.
As at the 30th of June 2013 the NAV of the Class A shares of the Pangolin Asia Fund was US$375.98 net of all fees and expenses, down 5.04% from US$395.94 in May. Please see the table at the end of this letter for further detail.
As at the 31st of May 2013 the NAV of the Class A shares of the Pangolin Asia Fund was US$395.94 net of all fees and expenses, up 5.83% from US$374.14 in April. Please see the table at the end of this letter for further detail.
As at the 30th of April 2013 the NAV of the Class A shares of the Pangolin Asia Fund was US$374.14 net of all fees and expenses, up 2.77% from US$364.05 in March. Please see the table at the end of this letter for further detail.
As at the 29th of March 2013 the NAV of the Class A shares of the Pangolin Asia Fund was US$364.05 net of all fees and expenses, up 3.76% from US$350.86 in February. Please see the table at the end of this letter for further detail.
As at the 28th of February 2013 the NAV of the Class A shares of the Pangolin Asia Fund was US$350.86 net of all fees and expenses, up 2.15% from US$343.47 in January. Please see the table at the end of this letter for further detail.
As at the 31st of January 2013 the NAV of the Class A shares of the Pangolin Asia Fund was US$343.47 net of all fees and expenses, up 1.23% from US$339.29 in December. Please see the table at the end of this letter for further detail.
As at the 31st of December 2012 the NAV of the Class A shares of the Pangolin Asia Fund was US$339.29 net of all fees and expenses, up 2.0% from US$332.63 in November. For the year we were up 24.9%. Please see the table at the end of this letter for further detail.
